Arkolith/Insider Trading/AKBA/Form 4

Frieson Ron

DirectorAkebia Therapeutics, Inc. (AKBA) · full profile →Form 4 · filed Jan 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 17, 2025Option exercise(M)20K$0.45$9K94K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 17, 2025Option exercise(M)20K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-000453) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML